Therapy of ANCA-associated systemic vasculitides: current approaches


P.I. Novikov, S.V. Moisseev, N.M. Bulanov, E.A. Makarov

1 Clinic of Nephrology, Internal and Occupational Diseases n.a. E.M. Tareev, ECH № 3, First MSMU n.a. I.M. Sechenov
Modern therapeutic approaches to treatment of ANCA-associated systemic vasculitides and algoritms of treatment choice are presented. Controlled clinical trials in patients with ANCA-associated systemic vasculitides are discussed. Role of target biological therapy of systemic vasculitides is reviewed.

About the Autors


Novikov P.I. - Head of the Rheumatological Department ECH № 3, Assistant Professor at Department of the Internal, Occupational Diseases and Pulmonology MPF First MSMU n.a. I.M. Sechenov, PhD in Medical Sciences
E-mail: novikov-pavel@mail.ru;
Moiseev S.V. - Professor at the Department of the Internal, Occupational Diseases and Pulmonology MPF First MSMU n.a. I.M. Sechenov, Professor at the Department of Internal Diseases FFM MSU n.a. M.V. Lomonosov, MD;
Bulanov N.M. – Postgraduate student at the Department of the Internal, Occupational Diseases and Pulmonology MPF First MSMU n.a. I.M. Sechenov;
Makarov E.A. – Postgraduate student at the Department of Internal Diseases FFM MSU n.a. M.V. Lomonosov


Similar Articles


Бионика Медиа